Clinical Trials Directory

Trials / Conditions / Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm

8 registered clinical trials studyying Malignant Genitourinary System Neoplasm — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingSurgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
NCT07215624
Wake Forest University Health Sciences—
RecruitingRole of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
NCT03819296
M.D. Anderson Cancer CenterPhase 1
RecruitingFecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genito
NCT04038619
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingInfliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourina
NCT04407247
M.D. Anderson Cancer CenterPhase 1 / Phase 2
CompletedPro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
NCT04456140
Mayo ClinicPhase 1
CompletedRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
NCT04501913
City of Hope Medical Center—
CompletedPharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
NCT04067960
Mayo ClinicEARLY_Phase 1
Active Not RecruitingCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourin
NCT02496208
National Cancer Institute (NCI)Phase 1